Introduction
============

*Stenotrophomonas maltophilia* is an aerobic, nonfermentative Gram-negative bacillus belonging to the gamma class of the proteobacteria ([@evv161-B26]). This ubiquitous bacterium can be found in various environments, such as water, soil, rhizosphere, plants, food, and hospital settings among others ([@evv161-B18]). In the soil and especially in the rhizosphere that are known to be its main habitats, *S. maltophilia* can engage in beneficial interactions with plants by promoting their growth and protecting them against fungal and bacterial plant pathogens ([@evv161-B78]). Some *S. maltophilia* strains are also known for their biotechnological potentials as they can contribute to bioremediation and phytoremediation strategies ([@evv161-B10]; [@evv161-B67]) and to the production of biomolecules of economic value ([@evv161-B78]). Nevertheless, in clinical environments *S. maltophilia* constitutes an emerging opportunistic pathogen responsible for a wide array of nosocomial infections, such as pneumonia, bloodstream and urinary tract infections, endocarditis, and meningitis among immunocompromised or debilitated patients as well as among patients with cystic fibrosis ([@evv161-B54]). Community-acquired infections are rare but documented ([@evv161-B27]).

One of the major features of clinical isolates of *S. maltophilia* is their high resistance levels toward most of the currently used antimicrobial agents, including β-lactams, carbapenems, macrolides, cephalosporines, fluoroquinolones, aminoglycosides, chloramphenicol, tetracyclines, and polymixines ([@evv161-B18]). Moreover, emerging resistance against the current "treatment of choice" trimethoprim--sulfamethoxazol is increasingly being reported in clinical isolates ([@evv161-B3]; [@evv161-B88]). Thus, therapy against infections caused by multidrug resistant (MDR) *S. maltophilia* presents a significant challenge for both clinicians and microbiologists. In its main habitat, *S. maltophilia* usually presents lower levels of resistance to antibiotics than clinical strains. However, in some instances, MDR isolates have been isolated from soils and aqueous environments ([@evv161-B15]; [@evv161-B8]). These MDR environmental strains may therefore constitute a public health risk.

*Stenotrophomonas maltophilia* display many intrinsic antibiotic resistance mechanisms such as low membrane permeability ([@evv161-B35]; [@evv161-B62]) and the presence of chromosomally encoded antibiotic modifying enzymes such as β-lactamases ([@evv161-B93], [@evv161-B94]; [@evv161-B11]) and other aminoglycoside phospho- and acetyl-transferases ([@evv161-B49]; [@evv161-B65]). But, like most other bacterial pathogens, the major intrinsic resistance mechanism responsible for its MDR phenotype can be attributed to the activity of chromosomally encoded multidrug efflux pumps ([@evv161-B96]; [@evv161-B16]). These pumps are capable of active extrusion of noxious compounds out of the cell and can be specific to a substrate or to a broad range of compounds ([@evv161-B64]). They are distributed among six families: The Multidrug and Toxic compound Extrusion (MATE) family, the small multidrug resistance (SMR) family, the major facilitator superfamily (MFS), the ATP-binding cassette (ABC)-transporter family, the resistance--nodulation--division (RND) family ([@evv161-B48]), and the fusaric acid resistance efflux pump family that has recently been described ([@evv161-B39]).

Efflux pump encoding genes are present in all bacterial chromosomes ([@evv161-B58]). In addition, efflux pumps provide resistance to many structurally different antibiotics, including quinolones, a family of synthetic antibiotics ([@evv161-B64]). Therefore, antibiotic resistance is probably only a secondary (more recent) function of these pumps. Indeed, some efflux pumps are involved in bacterial virulence, plant--bacteria interactions, trafficking of the quorum-sensing molecules and, more generally, in detoxification of not only intermediate metabolites or toxic compounds such as heavy metals and solvents, but also antibiotics naturally produced by other microorganisms ([@evv161-B9]). These initial (ecological) roles of the efflux pumps have been probably the main force responsible for their functional and structural diversity, as well as the spread of these efflux pumps through the whole bacterial domain. To understand the emergence of MDR phenotypes, it is important to focus on the roles and diversity of these efflux pumps in a nonclinical context, especially for opportunistic pathogens, which present particular predispositions to quickly develop new antibiotic resistances.

In *S. maltophilia*, the RND efflux pumps family and its involvement in MDR phenotypes are the most documented. The RND efflux systems generally form tripartite components composed of a periplasmic membrane fusion protein (MFP), an inner membrane RND transporter, and an outer membrane factor (OMF) ([@evv161-B48]). Eight RND efflux pumps, SmeABC, SmeDEF, SmeGH, SmeIJK, SmeMN, SmeOP-TolC, SmeVWX, and SmeYZ, have been identified in the first sequenced *S. maltophilia* genome ([@evv161-B22]). Among them, SmeABC, SmeDEF, SmeIJK, SmeOP-TolC, SmeVWX, and SmeYZ have been experimentally characterized and confirmed as involved in MDR phenotypes ([@evv161-B5]; [@evv161-B50]; [@evv161-B22]; [@evv161-B20]; [@evv161-B32]; [@evv161-B52]). Interestingly, a recent study has shown that the SmeIJK pump is probably involved also in cell envelope integrity maintenance, illustrating the multifunctionality of efflux pumps, including those involved in MDR phenotypes ([@evv161-B40]). Like in various other bacterial species and especially in Gram-negative bacteria, antibiotic resistance mechanisms can also be acquired by *S. maltophilia* through horizontal gene transfer (HGT) events associated with mobile DNA elements such as phages, integrons, transposons, and plasmids carrying antibiotic resistance genes ([@evv161-B12]; [@evv161-B51]; [@evv161-B38]). Nevertheless, in a start-up comparison of the two first sequenced genomes of *S. maltophilia*, it appeared that most antibiotic resistance genes, and especially the efflux pump encoding genes, are not associated with mobile genetic elements ([@evv161-B78]).

Whole-genome sequencing has become a powerful tool to address ecological questions in microbiology. The first *S. maltophilia* whole genome sequenced was that of the clinical MDR strain K279a isolated from a bloodstream infection ([@evv161-B22]). The study of the genomic content of this strain revealed a wide array of antibiotic resistance genes including many efflux pumps. Shortly thereafter, the whole-genome sequence of the endophytic strain R551-3 isolated from the poplar *Populus trichocarpa* was completed and compared with genomic sequences of other endophytes with the aim to start deciphering the mechanisms that underlie promotion of plant growth ([@evv161-B85]). Since the completion of these two whole-genome sequences, 11 other strains from clinical and environmental origin have been fully sequenced.

Antibiotic resistance profiles and the genes responsible for these properties, including those encoding efflux pumps of the RND family are well documented in a clinical context. Nevertheless, little is known in the environmental context. In this study, we tried to fill this gap by sequencing the whole genomes of three soil originating strains with known antibiotic resistance profiles, two of them showing higher antibiotic resistance levels than reference clinical MDR strains. These genomic data combined with those available in the public archives have constituted a good database for the implementation of a comparative genomic survey of the antibiotic resistance determinants of *S. maltophilia* to try deciphering the origin of efflux pumps associated with MDR phenotypes among environmental strains of *S. maltophilia*. In this study, the phylogenetic relationships between our three strains and the 11 genomes available in National Center for Biotechnology Information (NCBI) were investigated and the antibiotic resistance gene contents of these genomes were compared and discussed with regards to a strain's geographical origin and their antibiotic resistance phenotypes.

Materials and Methods
=====================

Bacterial Strains and Sampling Sites
------------------------------------

Three strains of *S. maltophilia* from our team's strain collection ([table 1](#evv161-T1){ref-type="table"}) were selected for genomic sequencing based on their particular antibiotic resistance profiles. Two of these strains (BurA1 and BurE1) were isolated, in the periphery of Ouagadougou, Burkina-Faso, from bulk soil samples collected in sorghum fields. The remaining strain (PierC1) was isolated from soil sampled from the Pierrelaye plain. This plain is heavily contaminated with heavy metals and antibiotics ([@evv161-B87]) as it was amended since the 1890s with raw wastewater from Paris, France. These three strains were isolated and identified as *S. maltophilia* as described by [@evv161-B69]. Table 1Source and Location of the *Stenotrophomonas maltophilia* Strains Studied*Stenotrophomonas maltophilia* StrainSourceLocationReferenceGenBank Accession NumberAntibiotic resistanceClinical origin    Ab55555ClinicalALOG00000000Unknown    AU12-09Catheter tip(Australia)[@evv161-B97]APIT00000000Unknown[^a^](#evv161-TF2){ref-type="table-fn"}    D457ClinicalMostoles (Spain)[@evv161-B53]NC_017671.1TET, ERY, NAL, NOR, OFX    K279aBlood infectionBristol (UK)[@evv161-B22]NC_010943.1Multi-drug[^b^](#evv161-TF3){ref-type="table-fn"}    S028SputumBeijing (China)[@evv161-B83]ALYK00000000Multi-drugEnvironmental origin    JV3Rhizosphere(Brazil)Lucas et al. (2011)NC_015947.1Unknown    PML168Rock poolWembury (UK)[@evv161-B4]CAJH00000000Unknown    R551-3Poplar tree endophyteWashington state (USA)Taghavi et al. ([@evv161-B85])NC_011071.1Sensitive[^b^](#evv161-TF3){ref-type="table-fn"}    RR10Rice rootZhejiang Province (China)[@evv161-B98]AGRB00000000Unknown[^a^](#evv161-TF2){ref-type="table-fn"}    SKA14Sea waterBaltic sea (Norway)Hagström et al. (2013)ACDV00000000Unknown    BurA1SoilOuagadougou (Burkina Faso)This studyMulti-drug[^b^](#evv161-TF3){ref-type="table-fn"}    BurE1SoilOuagadougou (Burkina Faso)This studyMulti-drug[^b^](#evv161-TF3){ref-type="table-fn"}    PierC1SoilPierrelaye (France)This studySensitive[^b^](#evv161-TF3){ref-type="table-fn"}Other origin    EPM1*Giardia duodenalis* culture contaminant(Portugal)Sassera et al. ([@evv161-B80])AMXM00000000Multi-drug[^a^](#evv161-TF2){ref-type="table-fn"}[^3][^4][^5]

Eleven previously sequenced strains from environmental (*n* = 5), clinical (*n* = 5), and other (*n* = 1) origins were included in the genomic analysis ([table 1](#evv161-T1){ref-type="table"}). The genome sequences were obtained from the NCBI (<http://www.ncbi.nlm.nih.gov/>) and are referenced with the accession numbers showed in the [table 1](#evv161-T1){ref-type="table"}. The clinical reference strain K279a ([@evv161-B11]) and the environmental reference strain R551-3 ([@evv161-B85]) were kindly provided by Dr Matthew B. Avison and Dr Daniel van der Lelie, respectively.

Antibiotic Resistance Test
--------------------------

The in vitro antimicrobial resistances of the three newly sequenced *S. maltophilia* strains and the two reference strains K279a and R551-3 were determined using the Vitek2 system with a NO93 card dedicated to nonfermenting Gram-negative bacteria (bioMérieux, Marcy l'Etoile, France) according to manufacturer instructions. Minimal inhibitory concentrations (MIC) of 18 antibiotics were determined. MIC results were analyzed by the AESTM (Advanced Expert System) software incorporated in this system. The disk diffusion method was also used for strains BurA1 and BurE1. The phenotype for aminoside resistance was compared with that of the reference strains *Escherichia coli* ATCC 25 922 as request by the CA-SFM/EUCAST (Antibiogram Committee of the French Microbiology Society) and *S. maltophilia* K279a.

Genome Sequencing, Assembly, and Annotation
-------------------------------------------

Genomic DNA of the three sequenced strains was extracted from an overnight culture grown in TSB medium at 28 °C under agitation at 180 rpm. The genomic DNA extraction protocol was achieved as described previously ([@evv161-B70]).

BurA1 whole genome was sequenced using a Roche 454 GS Junior sequencer (454 Life Sciences, Branford, CT) combined with an Illumina Hiseq 2000 approach (Illumina, San Diego, CA). The 454 run was performed at the University of Lyon (France) by the DTAMB/Biofidal structure and led to 131,210 reads with an average read length of 423 bp. The 2 × 100 bp paired-end Hiseq run was performed by Genoscreen society (Lille, France) with a final number of 2 × 73,799,133 reads. The 454 reads were first de novo assembled using Newbler 2.6 (Roche) with an estimated average coverage of 13-fold. Hiseq reads were then mapped on the de novo assembly using BWA-MEM software ([@evv161-B46]). The mapping of the Illumina reads raised the estimated coverage to 2,500-fold.

BurE1 and PierC1 whole genomes were sequenced at the University of Lyon (France) by the DTAMB/Biofidal structure using a Roche 454 GS Junior sequencer. For each strain, the number of reads was 186,793 and 160,103, respectively, with an average read lengths of 434 and 446 bp. The estimated average coverage was 18-fold and 15-fold, respectively.

For the three strains, the large contigs (size \> 500 bp) were reordered relative to the genome sequence of the reference strain K279a using the Mauve Contig Mover ([@evv161-B75]) of the MAUVE software ([@evv161-B24]). The contigs that could not be identified relative to the K279a genome sequence (one for each strain) were placed at the end of the alignment.

Coding sequences (CDSs) predictions, as well as automatic and manual sequence annotations, were performed using the MicroScope platform pipeline at Genoscope ([@evv161-B92]). Results are available through the MaGe graphical interface ([@evv161-B90]). CDSs were predicted using AMIGene software ([@evv161-B17]). Automatic functional annotation of the predicted CDSs was performed using the tools integrated in the MicroScope platform ([@evv161-B91]) and the available annotations of the strain K279a and other related genomes. Gene predicted to be involved in functions of interest was manually checked by using the "genome browser" tool of the platform. Genomic islands and regions of genomic plasticity (RGPs) of each genome were identified using the "RGP finder" tool included in the MicroScope platform by comparing the genome of each query against all the other studied genomes as reference.

The nucleotide sequences of the strains BurA1, BurE1, and PierC1 were deposited into European Nucleotide Archive (<http://www.ebi.ac.uk/ena>) with the accession numbers ERS685922, ERS685923, and ERS685924, respectively (the study accession is PRJEB8824).

Phylogenetic Analysis
---------------------

The evolutionary relationships among the 14 studied *S. maltophilia* strains were determined from a concatenated alignment of the orthologous protein sequences of the core genome of these 14 strains. Orthologous proteins were identified from bidirectional best hit BLASTP searches of each strain proteome against K279a's proteome with an *e*-value parameter threshold of 10e-5. Customized computer scripts were then used to extract the best reciprocal hits from all the strains and to align these protein sequences with Clustal omega ([@evv161-B81]). The alignments were then filtered using Gblocks version 0.91 b ([@evv161-B86]) with default options and concatenated. A final alignment of 1,647 concatenated proteins (514,787 amino acids) was used in the phylogenetic analyses. A phylogenetic tree was reconstructed with the maximum-likelihood method by implementation in RAxML V7.9.5 ([@evv161-B84]) with 1,000 bootstraps replicates. To root the phylogenetic tree, the same protocol was reiterated with the *Xanthomonas campestris* pv. *campestris* strain ATCC33913 genome as outgroup ([@evv161-B23]). In this case, a final alignment of 1,435 concatenated proteins (444,554 amino acids) was used in the analysis.

Additional phylogenetic studies were performed using different protein sequences (RND and integrase). In the same way as the phylogeny from orthologous proteins, the sequences were aligned with Clustal omega, then filtered using Gblocks. Phylogenetic tree was reconstructed with the maximum-likelihood method by implementation in RAxML V7.9.5 with 1,000 bootstraps replicates.

Antibiotic Resistance Gene and Efflux Pumps Content Identification
------------------------------------------------------------------

Antibiotic resistance genes and efflux pumps were identified by keyword searches after automatic and manual annotation of the CDS. Searches were also performed using InterPro database family identifier numbers ([@evv161-B41]). InterPro IDs were attributed to CDS by the InterProScan software ([@evv161-B73]) during the annotation process. Putative resistance and/or efflux functions were confirmed using BLASTP against the nonredundant protein sequence database. Known antibiotic resistance genes and efflux pumps described in *S. maltophilia* but not retrieved by the two previous methods were searched in the draft genomes by BLASTP searches after retrieving these sequences in the GenBanK database ([@evv161-B14]). We used an *e*-value parameter higher than 100 to confirm that no partial gene sequences were positioned at a contig extremity.

Results
=======

Antibiotic Susceptibility Profiles
----------------------------------

MICs across 18 antibiotics and combinations were tested using the Vitek2 system. *Stenotrophomonas maltophilia* strains showed differential susceptibilities as K279a, BurA1 and BurE1 showed low antibiotic susceptibility, whereas R551-3 showed intermediate susceptibility and PierC1 showed high susceptibility ([table 2](#evv161-T2){ref-type="table"}). Intermediate levels of resistance were considered as effective resistances. The two environmental MDR strains BurA1 and BurE1 showed increased resistances compared with strain K279a, the antibiotic resistant strain of reference. In contrast, the PierC1 strain showed a more sensitive phenotype than R551-3 that showed a medium resistance level. Strains BurA1 and BurE1 showed in vitro resistance to almost all the antibiotic classes assayed (resistance to 15 and 12 antibiotics over 18, respectively). These resistances encompass penicillins, cephalosporins, monobactam, carbapenems including meropenem, aminoglycosides, and polymixin. Although BurA1 is resistant to fluoroquinolones, all other strains except K279a were found to be sensitive. Reference clinical MDR strain K279a showed in vitro resistance to penicillins, carbapenems, aminoglycosides excepted isepamycin, fluoroquinolones and polymixin, but not to cephalosporins. Nevertheless, the MICs observed for penicillins, aminoglycosides, and polymixins classes of antibiotics were lower than those observed for the two environmental MDR strains. In contrast, PierC1 is sensitive to almost all antibiotics except imipenem from the carbapenems class of antibiotics. The strain R551-3 showed resistance toward the two carbapenems assayed, penicillins, cefepim from the cephalosporins class of antibiotics but not to ceftazidime. All strains were sensitive to ticarcillin from the penicillins class of antibiotics in combination with clavulanic acid and to minocycline from the tetracyclines class of antibiotics. Table 2Antibiotic MIC Profiles and Resistance Interpretation of *Stenotrophomonas maltophilia* Strains BurA1, BurE1, PierC1, K279a, and R551-3DrugClassBurA1BurE1PierC1K279aR551-3MIC (µg/ml)InterpretationMIC (µg/ml)InterpretationMIC (µg/ml)InterpretationMIC (µg/ml)InterpretationMIC (µg/ml)InterpretationTicarcillinCarboxypenicillin≥128R≥128R≤8S64R≥128RTicarcilline/ clavulanic acidCombinationNDND≤8S≤8S≤8S≤8SPiperacillinUreidopenicillin64R≥128R16S32I≥128RPiperacillin/ tazobactamCombination64R32I8SNDND64RCeftazidimeCephalosporin≥64R16R≤1S2S4SCefepimeCephalosporin32R32R≤1S4S16RAztreonamMonobactam≥64R≥64RNDND≥64R≥64RImipenemCarbapenem≥16R≥16R≥16R≥16R≥16RMeropenemCarbapenem≥16R≥16R≤0.25S≥16R≥16RAmikacinAminoglycoside≥64R≥64R≤2S16R4SGentamicinAminoglycoside≥16R≥16R≤1S8R≤1SIsepamycinAminoglycoside≥64R≥64R2S8S8STobramycinAminoglycoside8R≥16R≤1S≥16R≤1SCiprofloxacinFluoroquinolone2R1S0.5S2R0.5SPefloxacinFluoroquinolone2I1S1S2I0.5SMinocyclineTetracycline≤1S≤1S≤1S≤1S≤1SColistinPolymyxin≥16R≥16R≤0.5S8R≤0.5STrimethoprim/ sulfamethoxazoleSulfonamide40S≤20S≤20S≤20S≤20S[^6]

General Features of the Sequenced Genomes
-----------------------------------------

The general genomic features of the three novel *S. maltophilia* environmental strains sequenced in this study are summarized in the [table 3](#evv161-T3){ref-type="table"}. The draft genomes of BurA1, BurE1 and PierC1 consisted of approximately 4,366,960, 4,509,290 and 4,644,375 bp circular chromosomes assembled in 64, 48, and 59 contigs of size greater than 500 bp, respectively. No plasmids were detected in the genome assemblies or by Pulse Field Gel Electrophoresis (PFGE) (data not shown). The average G+C % of BurA1 and BurE1 was 66.6% and this of PierC1 was 66.3%. These data are consistent with the average G+C % of the other *S. maltophilia* genomes ([table 3](#evv161-T3){ref-type="table"}). In total, 4,132, 4,223 and 4,422 predicted protein-CDSs were identified in the genomes of BurA1, BurE1 and PierC1, respectively, with an average CDS length of 952--962 bp and a coding density of 89.5--89.7%. These general CDSs features are also consistent with the CDSs features observed in the other strains ([table 3](#evv161-T3){ref-type="table"}). Sixty, 65 and 64 transfer RNA genes were, respectively, found among the genomes of BurA1, BurE1 and PierC1, which is within the range of what is observed among the other genomes. The ribosomal RNA operons copy number could not be determined because the three genomes were not finished and all the reads corresponding to these genomic regions were aligned and assembled in one operon by the assembling software. Between 91 and 101 RGPs were identified among each genome. Table 3General Genomic Features of the *Stenotrophomonas maltophilia* Strains Obtained from the MicroScope Annotation Platform and from the GenBank PlatformStrainsAb55555[^a^](#evv161-TF6){ref-type="table-fn"}AU12-09[^a^](#evv161-TF6){ref-type="table-fn"}D457[^a^](#evv161-TF6){ref-type="table-fn"}EPM1[^a^](#evv161-TF6){ref-type="table-fn"}K279a^a^S028[^a^](#evv161-TF6){ref-type="table-fn"}BurA1[^b^](#evv161-TF7){ref-type="table-fn"}BurE1[^b^](#evv161-TF7){ref-type="table-fn"}PierC1[^b^](#evv161-TF7){ref-type="table-fn"}JV3[^c^](#evv161-TF8){ref-type="table-fn"}PML168[^c^](#evv161-TF8){ref-type="table-fn"}R551-3[^c^](#evv161-TF8){ref-type="table-fn"}RR10[^c^](#evv161-TF8){ref-type="table-fn"}SKA14[^c^](#evv161-TF8){ref-type="table-fn"}Chromosome size (megabase pairs)4.94.554.774.794.853.754.364.54.644.544.44.574.685.02PlasmidNoNoNoNoNoNoNoNoNoNoNoNoNoNoG+C (%)66.166.566.866.466.367.166.666.666.366.966.666.366.366.4Protein-CDSs4,7394,0044,5994,5914,7603,6864,1324,2234,4224,2224,2284,1704,5084,788Average CDS length (nt)937NA930945934949954962952972957989936954Coding density (%)89.1NA88.589.689.39189.589.589.789.590.389.589.390.5Ribosomal RNA operons2NA444NANANANA434NA4Transfer RNA genes70707166743760656473577310670\# scaffolds64111111111113\# contigs211251191297644859193115849RGPs94NA9694949295921019595959199[^7][^8][^9][^10]

*Stenotrophomonas maltophilia* Core Genome and Phylogeny
--------------------------------------------------------

Using reciprocal BLASTP, protein-coding genes having a 1:1 orthologous relationship to each other were identified across the 14 available *S. maltophilia* genomes. A total of 1,647 CDSs were identified which could be considered the core set of orthologous genes, at least for those 14 strains. To root the phylogenetic tree, the core genome analysis was performed with a *Xanthomonas campestris* pv. *campestris* strain as outgroup. All the *S. maltophilia* and the *Xanthomonas* strains shared 1,435 orthologous proteins concatenated in an alignment of 444,554 amino acids used for phylogenetic tree reconstruction by maximum-likelihood method ([fig. 1](#evv161-F1){ref-type="fig"}). Most of strains not grouped within clusters are from environmental origin, and the different clades revealed by the phylogenetic analysis are consistent neither with the sampling origin of the strains nor with their antibiotic resistance phenotypic properties ([fig. 1](#evv161-F1){ref-type="fig"}). Indeed, clusters including both clinical and environmental strains have been revealed by the phylogeny. As an example, strain BurE1, isolated from Burkinabe soils, clustered with K279a and Ab55555 from clinical origin and EPM1, which is a laboratory culture contaminant. Moreover, the two clinical strains, D457 from Spain and AU12-09 from Australia, clustered with strain JV3 which was isolated from a rhizosphere sample from Brazil. This confirms that the core genome phylogeny does not allow the clustering of the strains according to their geographical origin and/or their habitat (i.e., environmental vs. clinical strains). In the same way, this phylogeny does not permit the discrimination of the MDR and antibiotic sensitive strains. Despite the lack of information for many sequenced strains, sensitive and resistant strains seem to group within different clusters ([fig. 1](#evv161-F1){ref-type="fig"}). The antibiotic sensitive strains PierC1 and R551-3 that show intermediate levels of resistance are not grouped with other strains. Remarkably, the environmental MDR strain BurE1 is genetically close to three strains, including two MDR strains, K279a and EPM1. Unfortunately, the antibiotic resistance profile of the fourth strain of this clade, Ab55555, remains unknown. The environmental MDR strain BurA1 forms a clade with the strain RR10, which was isolated from a rice plant rhizosphere and is not related to antibiotic resistant strains, even if the presence of many antibiotic resistance genes in its genome was previously reported ([@evv161-B98]). F[ig]{.smallcaps}. 1.---Phylogenetic tree from maximum-likelihood analysis of the core-genome alignments of the 14 strains of *S. maltophilia* and *X. campestris* pv *campestris* strain ATCC33913. In total, 1,435 orthologous proteins were concatenated in an alignment of 444,554 amino acids. Bootstraps are indicated at each node. Strains highlighted in green are from environmental origin, in red from clinical origin, and in blue from other origin. Strain names followed by a plain triangle are MDR; those followed by a plain circle are sensitive. Antibiotic resistance profiles of the strains followed by squares are unknown but presence of antibiotic resistance genes was related in the genome references of the strains followed by plain squares.

Overview of Antibiotic Resistance Genes
---------------------------------------

Antibiotic resistance genes were sought primarily in the genomes of the environmental strains sequenced in this study as well as in those of the reference strains K279a and R551-3 for which accurate data on their drug resistance profiles were available. On the basis of the core-genome phylogenetic clustering of the sequenced strains, other publicly available sequenced strains such as Ab55555, which clustered with strains BurE1 and K279a, and strain RR10, phylogenetically close to the strain BurA1, were added in the analysis. Strains D457 and JV3 grouped together and were included in the survey.

Between 50 and 56 known or putative antibiotic resistance genes and efflux pumps commonly considered to be implied in MDR phenotypes were found among the nine strains, including genes involved in resistance to beta-lactam compounds such as penicillins and carbapenems, as well as aminoglycosides and quinolones ([fig. 2](#evv161-F2){ref-type="fig"}). The number of identified genes cannot be linked with the resistance profiles observed. Indeed, the same number of resistance genes (*n* = 56) was found in the sensitive strain PierC1 and in the multiresistant strain K279a. Similarly, the intermediate resistant strain R551-3 and the multiresistant strain BurE1 share the same number of resistance genes (*n* = 54). Moreover, the lowest amount of resistance genes (*n* = 50) was found in the strain BurA1, which showed the highest resistance level among the studied strains. F[ig]{.smallcaps}. 2.---Summary of the antibiotic resistance genes and operons present in each *S. maltophilia* strains. Multidrug efflux pumps operons are counted as one even if encoded by multiple genes. No tetracycline and sulfonamide resistance genes were found.

Three known beta-lactamase encoding genes are shared by all the strains: *bla*L1 encoding a metallo-beta-lactamase, which is suspected to confer resistance to imipenem as well as *bla*L2 and *amp*C, which are cephalosporinase-like enzymes ([table 4](#evv161-T4){ref-type="table"}). Between 13 and 18 putative beta-lactamase encoding genes were found in each strain, with 12 genes shared by all the strains. Nevertheless, the number of known or putative beta-lactam genes present in each genome does not allow the distinction of the resistance phenotype of the different strains against this class of antibiotic as beta-lactam resistant strains do not carry an increased number of genes encoding beta-lactamase proteins compared with sensitive ones. For instance, the same number of putative beta-lactamase encoding genes has been detected among the sensitive strain PierC1 and the resistant strain K279a (*n* = 21) ([fig. 2](#evv161-F2){ref-type="fig"}). These 2 genomes share 19 putative beta-lactamase encoding genes, 2 of them being unique to each genome ([table 4](#evv161-T4){ref-type="table"}). Moreover strains BurA1 and BurE1, which are resistant to almost all the tested antibiotics belonging to the beta-lactams, show a lower number of genetic determinants involved or putatively involved in resistance to beta-lactams. Similarly, the presence of the characterized cephalosporinases AmpC and BlaL2 in all the strains did not allow inference about their resistance profile for these antibiotics, PierC1 and K279a harboring these two genes but being sensitive to cephalosporins. Table 4Summary of the Antibiotic Resistance Genes Found among the Nine Strains of *Stenotrophomonas maltophilia* and Their Related Locus TagK279aBurE1Ab55555BurA1RR10D457JV3R551-3PierC1Known β-lactam resistance genes    ampCSmlt_0115SmBFE_10085ALOG_10036SMBUR_70127AGRB_1350003SMD_0070BurJV3_0070Smal_0071SmPIER_10096    Metallo-beta-lactamase l1 (*bla*L1)Smlt_2667SmBFE_210322ALOG_110253SMBUR_60016AGRB_830068SMD_2343BurJV3_2191Smal_2146SmPIER_360009    Beta-lactamase l2 (*bla*L2)Smlt_3722SmBFE_330045ALOG_130919SMBUR_310038AGRB_900050SMD_3327BurJV3_3170Smal_3136SmPIER_500109*Putative* β*-lactam resistance genes*    Metallo-beta-lactamase family proteinSmlt_0347SmBFE_30019ALOG_20149SMBUR_130078AGRB_1310078SMD_0282BurJV3_0271Smal_0244SmPIER_20102    Putative beta-lactamase (PBP 4)Smlt_0462SmBFE_50045ALOG_30046SMBUR_300002AGRB_310002SMD_0391BurJV3_0373Smal_0343SmPIER_60045    Putative beta-lactamaseSmlt_0523SmBFE_70005ALOG_30105SMBUR_250009AGRB_1060016SMD_0441BurJV3_0424Smal_0402SmPIER_60109    Putative metallo beta-lactamase family proteinSmlt_0580SmBFE_80053ALOG_30160SMBUR_230020AGRB_1080022SMD_0495BurJV3_0475Smal_0456SmPIER_60162    Putative metallo beta-lactamase family proteinSmlt_0581SmBFE_80054ALOG_30161SMBUR_230019AGRB_1080023SMD_0496BurJV3_0476Smal_0457SmPIER_60163    Putative beta-lactamaseSmlt_1470SmBFE_180025ALOG_60039SMBUR_80088AGRB_910017SMD_1305BurJV3_1223Smal_1234SmPIER_160175    Putative metallo-beta-lactamase superfamily proteinSmlt_1815SmBFE_190085ALOG_60526SMBUR_190042AGRB_1210006SMD_1751BurJV3_1601Smal_1554SmPIER_170243    Putative beta-lactamaseSmlt_3114SmBFE_280113ALOG_130332SMBUR_30157AGRB_840024SMD_2694BurJV3_2565Smal_2553SmPIER_440066    Putative beta-lactamaseSmlt_3495SmBFE_300159ALOG_130697SMBUR_40170AGRB_750011SMD_3077BurJV3_2956Smal_2923SmPIER_460297    Putative beta-lactamaseSmlt_3652SmBFE_320074ALOG_130847SMBUR_360003AGRB_1350018SMD_3220BurJV3_3098Smal_3068SmPIER_500018    Putative metallo-beta-lactamase superfamily proteinSmlt_3807SmBFE_330125ALOG_150056SMBUR_200003AGRB_1380014SMD_3409BurJV3_3251Smal_3222SmPIER_500189    Putative metallo-beta-lactamase superfamily proteinSmlt_3991SmBFE_370133ALOG_160174SMBUR_90113AGRB_550016 - 1330023SMD_3590BurJV3_3439Smal_3401SmPIER_500370    Putative beta-lactamaseSmlt_2514NoNoSMBUR_60142NoNoNoSmal_2001SmPIER_520126    Putative penicillin-binding protein/beta-lactamaseSmlt_2563SmBFE_210214ALOG_110150SMBUR_60096AGRB_970014SMD_2246NoNoSmPIER_390020    Putative beta-lactamase AmpC proteinSmlt_2589SmBFE_210238ALOG_110176NoNoNoNoNoSmPIER_340017    Putative beta-lactamaseSmlt_3132NoNoNoAGRB_840044SMD_2710NoSmal_2573No    Putative beta-lactamaseSmlt_4159SmBFE_380035ALOG_160338SMBUR_10037NoNoNoNoNo    Putative beta-lactamaseSmlt_4211SmBFE_380084ALOG_160388NoAGRB_1510036SMD_3811BurJV3_3660NoSmPIER_530027    Beta-lactamase domain containing proteinNoNoNoNoNoNoNoNoSmPIER_180030    Putative beta-lactamaseNoNoNoNoNoNoNoNoSmPIER_460142    Putative beta-lactamaseNoNoNoNoNoNoNoSmal_3669No    Beta-lactamase class CNoNoNoNoNoSMD_2256NoNoNoKnown and putative aminoglycoside resistance genes    Putative aminoglycoside phosphotransferaseSmlt_0191SmBFE_20029ALOG_20042SMBUR_180020AGRB_1220017SMD_0160BurJV3_0146Smal_0151SmPIER_10177    Putative aminoglycoside phosphotransferaseSmlt_1131SmBFE_170042ALOG_50153SMBUR_100042AGRB_790032SMD_1054BurJV3_0970Smal_0976SmPIER_120004    Putative aminoglycoside 3′-phosphotransferaseSmlt_2120SmBFE_200047ALOG_60817SMBUR_50152AGRB_1250024SMD_1909BurJV3_1756Smal_1717SmPIER_180077    Putative spectinomycin phosphotransferaseSmlt_2125SmBFE_200051ALOG_60821SMBUR_50156AGRB_1250028SMD_1912BurJV3_1759Smal_1721SmPIER_180080    Streptomycin 3″-phosphotransferaseSmlt_2336SmBFE_210106ALOG_110013SMBUR_160072AGRB_860077SMD_2105BurJV3_1980Smal_1923SmPIER_31001    Putative aminoglycoside 2′-*N*-acetyltransferaseSmlt_1669SmBFE_180214ALOG_60334NoAGRB_830023NoNoNoNo    Aminoglycoside 6′-*N*-acetyltransferase (*aac(6\')-iz*)Smlt_3615SmBFE_320037ALOG_130811NoNoNoNoNoNo    Dimethyladenosine transferase (*ksgA*)Smlt_0818SmBFE_100026ALOG_30377SMBUR_20181AGRB_1140003SMD_0699BurJV3_0680Smal_0668SmPIER_60395Putative chloramphenicol resistance gene    Putative chloramphenicol acetyltransferase (*cat*)Smlt_0620NoNoNoNoNoNoNoSmPIER_60202Known fluoroquinolones resistance gene    Putative fluoroquinolone resistance protein qnrB (*smqnr*)Smlt_1071SmBFE_160067ALOG_50092SMBUR_100101AGRB_720043SMD_0998BurJV3_0908Smal_0911SmPIER_110039Other antibiotic resistance gene    Phosphomannomutase/phosphoglucomutase (*spg*M)Smlt_0403SmBFE_30067ALOG_20199SMBUR_390016NoSMD_0323BurJV3_0314Smal_0286SmPIER_30018

Aminoglycoside phosphotransferase and aminoglycoside acetyltransferase enzymes mediate resistance to aminoglycoside drug class. All the strains carry five genes encoding putative or characterized aminoglycoside phosphotransferase enzymes including streptomycin 3′-phosphotransferase and spectinomycin phosphotransferase ([table 4](#evv161-T4){ref-type="table"}). Two putative aminoglycoside acetyltransferases were found among the genomes but they were not present in each strain. A putative aminoglycoside 2′-*N*-acetyltransferase was found in strains K279a, BurE1, and Ab55555 belonging to the same phylogenetic cluster, as well as in strain RR10. The characterized aminoglycoside 6′-*N*-acetyltransferase gene *aac*(6′)-iz encoding an aminoglycoside modifying enzyme responsible for the resistance toward amikacin, netilmicin, sisomicin, and particularly tobramycin was found in strains K279a, BurE1, and Ab55555. The BurA1 strain did not carry aminoglycoside acetyltransferase genes although it showed the same aminoglycoside resistance levels than the BurE1 strain and even higher resistance level than the strain K279a. On the opposite with the same aminoglycoside resistance gene content than the strain BurA1, PierC1 showed a sensitive phenotype. Thus, aminoglycoside resistance in BurA1 could result from specific membrane permeability and efflux pump content. The dimethyladenosine transferase *ksg*A gene involved in resistance to kasugamycin was also found in all the genomes.

All the strains also carry the Sm*qnr* chromosomal quinolone resistance gene. Nevertheless, among the five strains for which the antibiotic resistance profiles are available, only BurA1 and K279a are resistant to both fluoroquinolones assayed.

All strains but RR10 share the phosphoglucomutase *spg*M gene associated with resistance to polymyxin B, polymixin E, nalidixic acid, gentamicin, vancomycin, ceftazidime, ticarcillin--clavulanic acid, and piperacillin--tazobactam ([@evv161-B51]). *SpgM* is not formerly an antibiotic resistance determinant as it encodes a phosphoglucomutase enzyme associated with lipopolysaccharides (LPS) biosynthesis. Nevertheless, it was shown to be moderately involved in antimicrobial resistance and in virulence ([@evv161-B61]).

The putative chloramphenicol resistance gene *cat* was found in strains K279a and PierC1.

No resistance genes were found for the tetracycline and sulfonamide classes.

Efflux Pumps Related to Drug Resistance
---------------------------------------

Given their prominent role in the antibiotic resistance in *S. maltophilia*, efflux pumps involved or putatively involved in drug-resistance were investigated in greater detail. Each of the six efflux pump families was explored for efflux systems involved in drug-resistance and antimicrobial-resistance. Efflux pumps related to metal compound resistance are not discussed here. In terms of presence/absence of genetic determinants encoding efflux pumps, little to no differences were observed between the nine genomes investigated ([fig. 3](#evv161-F3){ref-type="fig"}). No correlation could be made between the number of putative and known MDR efflux pumps found in each genome and the antibiotic resistance phenotypes observed. As an example, the largest number of MDR efflux pumps (*n* = 28) was found in the environmental strain R551-3 that shows resistance toward fewer antibiotics than the MDR clinical strain K279a that harbors 24 MDR efflux systems ([fig. 3](#evv161-F3){ref-type="fig"}). Similarly the extremely sensitive strain PierC1 harbors 26 MDR efflux systems likely to contribute to antibiotic resistance whereas BurA1 and BurE1, which are resistant to many antibiotics, carry 24 and 25 MDR efflux systems respectively. F[ig]{.smallcaps}. 3.---Summary of the known and putative multidrug efflux pumps found in the nine strains of *S. maltophilia*.

The MATE Family
---------------

MATE efflux pumps can export xenobiotic compounds like antibiotics of the quinolone class, antimicrobials and dyes, out of the bacterial cell. They are composed of a single transmembrane protein encoded by a single gene ([@evv161-B44]). Three genes encoding MATE efflux pumps were found among the studied genomes, two of them being present in all of the strains ([table 5](#evv161-T5){ref-type="table"}). One of those encodes an efflux pump homologous to the characterized PmpM MATE efflux pump from *Pseudomonas aeruginosa* with translated amino acid sequence identity of about 40% over 99% of the protein sequence. The PmpM efflux pump confers resistance against ciprofloxacin, norfloxacin, ofloxacin, and against antimicrobials such as acriflavin and benzalkonium chloride. It is also known to extrude ethidium bromide out of the cell. The second gene encoding a MATE efflux pump found in all the strains possesses no characterized homolog. Nevertheless, its translated amino acid sequence shows conserved domains related to the NorM efflux pump described in *Vibrio parahaemolyticus* and *Escherichia coli*. Like PmpM and the other characterized MATE efflux pumps, the NorM efflux pump is known to confer resistance against quinolones and others antimicrobials. The third gene encoding a MATE efflux pump was found in all the strains excepted R551-3 and PierC1. Its translated amino acid sequence also shares conserved protein domains with the NorM efflux pump from *V. parahaemolyticus* and *E. coli*. Table 5Summary of the Efflux Pumps Involved or Putatively Involved in MDR Phenotype Found among the Nine Strains of *Stenotrophomonas maltophilia*FamilyGene/homologK279aBurE1Ab55555BurA1RR10JV3D457R551-3PierC1SubstrateLocusIDLocusIDLocusIDLocusIDLocusIDLocusIDLocusIDLocusIDMATE*pmp*Msmlt1381SmBFE_17022798.8ALOG_5036099SMBUR_8001197.3AGRB_90009497.9BurJV3_114697.3SMD_123398.6Smal_116096.7SmPIER_16009191.7Ciprofloxacin, norfloxacin, ofloxacin, acriflavin, benzalkonium chloride, EtBrsmlt2970SmBFE_28002293.4ALOG_13022495.1SMBUR_3022789.2AGRB_119004392.7BurJV3_247991.2SMD_260890.8NoNoNoNo\[quinolones, antimicrobials, dyes\]*nor*Msmlt4191SmBFE_38006499.6ALOG_16036799.8SMBUR_1006799.1AGRB_151001498.7BurJV3_364098SMD_379097.8Smal_359897.8SmPIER_53000597.1SMR*sug*Esmlt1007SmBFE_150007100ALOG_50022100SMBUR_2000298.1AGRB_43000299.1BurJV3_085999.1SMD_94698.1Smal_085398.1SmPIER_9010898.1CTAB, cetylpyridinium chloride, cetylpyridinium bromide, cetyldimethylethyl ammonium bromide*emr*Esmlt3363SmBFE_30002799.1ALOG_13056999.1SMBUR_12003298.2AGRB_68007092.3BurJV3_281192.3SMD_293593.6Smal_278796.4SmPIER_46011590.9Methyl viologen, tetraphenylphosphonium, benzalkonium, CTAB, cetylpyridinium chloride, EtBr, acriflavin/proflavin, crystal violet, pyronine, safranine, ampicillin, erythromycin, tetracycline*sug*Esmlt4304SmBFE_380178100ALOG_160482100SMBUR_1017099.1AGRB_470010100BurJV3_3746100SMD_389899.1Smal_371399.1SmPIER_55000596.2CTAB, cetylpyridinium chloride, cetylpyridinium bromide and cetyldimethylethyl ammonium bromideMFS*emr*Asmlt1529SmBFE_180083100ALOG_60096100SMBUR_8014699.5AGRB_73002299BurJV3_127998.7SMD_136099.5Smal_128898.5SmPIER_16023097.7Carbonyl cyanide m-chlorophenylhydrazone, tetrachlorosalicylanilide, organomercurials, nalidixic acid, thiolactomycin*emr*Bsmlt1530SmBFE_18008499.8ALOG_60097100SMBUR_8014799.2AGRB_73002399.1BurJV3_128099.2SMD_1361100Smal_128997.4SmPIER_16023197.5OMFsmlt1528SmBFE_18008299ALOG_6009599SMBUR_8014597.2AGRB_73002198.6BurJV3_127895.4SMD_135997.6Smal_128794.4SmPIER_16022992.4*bcr*smlt3578SmBFE_32000399.3ALOG_13077599.3SMBUR_26002598.8AGRB_134000397.3BurJV3_302998.1SMD_315097.8Smal_299996.8SmPIER_48001992.4Bicyclomycin, sulfathiazole, chloramphenicol*mdt*Dsmlt3623SmBFE_32004599.8ALOG_130819100SMBUR_29002799.4AGRB_25000899.6BurJV3_306898.3SMD_319298.7Smal_304098.7SmPIER_49002196.4UnknownOMFsmlt3969SmBFE_37011099.6ALOG_16015199.6NoNoAGRB_36002595.3BurJV3_341697SMD_356897.9Smal_337897SmPIER_50034991.8Carbonyl cyanide m-chlorophenylhydrazone, tetrachlorosalicylanilide, organomercurials, nalidixic acid, thiolactomycin*emr*Asmlt3970SmBFE_370111100ALOG_16015299.7NoNoAGRB_36002696.9BurJV3_341795.6SMD_356998.1Smal_337999.4SmPIER_50035089.2*emr*Bsmlt3971SmBFE_37011299.8ALOG_16015399.8NoNoAGRB_36002799.2BurJV3_341898.6SMD_357099.6Smal_338098.4SmPIER_50035194.8*bcr*/*cfl*ANoNoNoNoNoSMBUR_1002981.5AGRB_15001683.9NoNoNoNoSmal_3550SmPIER_52011376.4Bicyclomycin, sulfathiazole, chloramphenicolABC*smr*Asmlt1471SmBFE_18002699.8ALOG_6004099.7SMBUR_8008999.2AGRB_91001898.7BurJV3_122499.8SMD_130699.3Smal_123597.9SmPIER_16017696.6Ciprofloxacin; norfloxacin, ofloxacin, tetracycline, doxorubicin, dyesOMFsmlt1537SmBFE_18009099.8ALOG_6010499.6SMBUR_11000495AGRB_73003098.3BurJV3_128695.8SMD_137095.2Smal_129695SmPIER_16023792Macrolides*mac*Bsmlt1538SmBFE_18009199.9ALOG_60105100SMBUR_11000598.5AGRB_73003198.8BurJV3_128798.5SMD_137198.2Smal_129797.9SmPIER_16023894.2*mac*Asmlt1539SmBFE_18009299.5ALOG_60106100SMBUR_11000696.4AGRB_73003298.8BurJV3_128897.3SMD_137298.1Smal_129896.9SmPIER_16023993.2smlt1597SmBFE_18015299.4ALOG_6016398.4SMBUR_11006289.9AGRB_81003192.8BurJV3_134491.5SMD_142391.2Smal_135491.1SmPIER_17003278.9Unknownsmlt1598SmBFE_18015399.7ALOG_6016499SMBUR_11006393.2AGRB_81003294.8BurJV3_134596.9SMD_142496.1Smal_135591.5SmPIER_17003390.2smlt1599SmBFE_18015498.7ALOG_6016599.5SMBUR_11006497.6AGRB_81003397.8BurJV3_134697.8SMD_142597.8Smal135698.1SmPIER_17003493.2*mac*Asmlt2642SmBFE_21029399.2ALOG_110229100SMBUR_6003799.2NoNoBurJV3_212990.9SMD_231292.1Smal_211591.1NoNoMacrolides*mac*Bsmlt2643SmBFE_21029499.5ALOG_110230100SMBUR_6003699.4NoNoBurJV3_213088.8SMD_231388.6Smal_211688.3NoNo*mac*ANoNoNoNoNoNoNoAGRB_118002992.2BurJV3_253086.2SMD_265989.4Smal_2466SmPIER_43005586.9Macrolides*mac*BNoNoNoNoNoNoNoAGRB_118003095.2BurJV3_253186.9SMD_266090.8Smal_2467SmPIER_43005690.3Fusaric acid resistance*fua*Asmlt2796SmBFE_23005491.8ALOG_13005095.2SMBUR_34001593.1AGRB_99006989.3NoNoSMD_244789.4Smal_225389.4SmPIER_40003171.8Fusaric acid*fua*Bsmlt2797SmBFE_23005696.6ALOG_13005295.6SMBUR_34001394.9AGRB_99007193.2NoNoSMD_244996.6Smal_225592.9SmPIER_40003384*fua*Csmlt2798SmBFE_23005796.2ALOG_13005392.3SMBUR_34001292.7AGRB_99007288.2NoNoSMD_245091.6Smal_225693.3SmPIER_40003470.1smlt4662SmBFE_42001698.7ALOG_21002199SMBUR_7001695.1AGRB_104001795.1BurJV3_405596.7SMD_420598.4Smal_400997.1SmPIER_57001594.1Fusaric acidsmlt4663SmBFE_42001799.4ALOG_21002298.8SMBUR_7001797.7AGRB_1040018NDBurJV3_405696.9SMD_420697.5Smal_401096.9SmPIER_57001694.4smlt4664SmBFE_42001899.1ALOG_21002399.3SMBUR_7001898.2gapNDBurJV3_405797.9SMD_420798.7Smal_401198.5SmPIER_57001795.1RND*sme*VSmlt1830SmBFE_19010099.7ALOG_60541100SMBUR_19005798.2AGRB_121002099.7BurJV3_161598.3SMD_176498.7Smal_156798.5SmPIER_17025795.4Chloramphenicol, tetracyclines, quinolones*sme*WSmlt1831SmBFE_190101100ALOG_60542100SMBUR_19005899.8AGRB_121002199.8BurJV3_161699.3SMD_176599.4Smal_156898.2SmPIER_17025894.9*sme*XSmlt1833SmBFE_19010399.6ALOG_6054499.8SMBUR_19006098.3AGRB_121002399.4BurJV3_161896.6SMD_176797.9Smal_157097.9SmPIER_17026097.5*sme*Ysmlt2201SmBFE_20014299.5ALOG_6093299.7SMBUR_15004098.1AGRB_127001997.3BurJV3_185296.5SMD_198295.2Smal_179397.6SmPIER_25001690.9Gentamycin, kanamycin, amikacin, tobramycin*sme*Zsmlt2202SmBFE_20014399.6ALOG_6093399.8SMBUR_15003999.1AGRB_12800199.3BurJV3_185398.7SMD_198398.4Smal_179497.8SmPIER_25001793.6*sme*Gsmlt3170SmBFE_28016398.4ALOG_13038798.4SMBUR_3010596.7AGRB_84009797.4BurJV3_262097.9SMD_274896.7Smal_260797.6SmPIER_44012592.5Unknown*sme*Hsmlt3171SmBFE_28016499.9ALOG_13038899.8SMBUR_3010499.2AGRB_84009899.1BurJV3_262199.2SMD_274998.9Smal_260899.1SmPIER_44012698.2*sme*Msmlt3788SmBFE_33010999.7ALOG_15004099.7SMBUR_4011995.4AGRB_137003695.4BurJV3_323594SMD_339295.9Smal_320492.4SmPIER_50017189.7Unknown*sme*Nsmlt3787SmBFE_33010898.7ALOG_15003999.8SMBUR_4011899AGRB_137003598.9BurJV3_323498.9SMD_339198.9Smal_320398.8SmPIER_50017097.8*sme*Osmlt3925SmBFE_370065100ALOG_16010399.7SMBUR_9005798.1AGRB_144000599.2BurJV3_337697.3SMD_352897.9Smal_334077.3SmPIER_50030575.7Nalidixic acid, doxycycline, amikacin, gentamycin, erythromycin, leucomycin*sme*Psmlt3924SmBFE_37006499.6ALOG_16010299.7SMBUR_9005699AGRB_144000499.5BurJV3_337598.6SMD_352798.7Smal_333991.3SmPIER_50030491.5*tol*Csmlt3928SmBFE_370068100ALOG_160106100SMBUR_9006097.4AGRB_144000899.1BurJV3_337997.8SMD_353197.8Smal_334395.8SmPIER_50030893.1*sme*Dsmlt4072SmBFE_37020099ALOG_16024699.8SMBUR_22005198.7AGRB_96001696.7BurJV3_350997SMD_365897.7Smal_346895.7SmPIER_52002895.4Tetracycline, chloramphenicol, erythromycin, quinolones*sme*Esmlt4071SmBFE_37019999.5ALOG_160245100SMBUR_22005299.5AGRB_96001799.4BurJV3_350898.9SMD_365799.1Smal_346796SmPIER_52002794.3*sme*Fsmlt4070SmBFE_37019899.6ALOG_16024499.8SMBUR_22005396.5AGRB_96001896.5BurJV3_350796.3SMD_365698.3Smal_346697SmPIER_52002692.8*sme* Ismlt4279SmBFE_38015299.8ALOG_16045699.5SMBUR_1014597.8AGRB_56001096.9BurJV3_372397.1SMD_387396.4Smal_368996.1SmPIER_54006095.4Gentamycin, amikacin, tetracycline, minocyclin, ciprofloxacin, levofloxacin*sme* Jsmlt4280SmBFE_38015399.9ALOG_16045799.7SMBUR_1014699.4AGRB_56000998.8BurJV3_372499SMD_387499.4Smal_369098.6SmPIER_54006196*sme* Ksmlt4281SmBFE_38015499.9ALOG_16045899.9SMBUR_1014798.9AGRB_56000897.9BurJV3_372598.7SMD_387599.4Smal_369197.8SmPIER_54006296.4*sme*Asmlt4476SmBFE_40000898.5ALOG_18004898.2NoNoAGRB_76003596.5BurJV3_388595.5SMD_402394Smal_383892.2NoNoPenicillin, carbenicillin, ampicillin, cefsulodin, cefotaxime, cefoperazone, cefepime, cefpirome, amikacine, gentamycine, kanamycine, streptomycin*sme*Bsmlt4475SmBFE_40000799.5ALOG_18004799.8NoNoAGRB_76003697.5BurJV3_388498.3SMD_402297.6Smal_383798.3NoNo*sme*Csmlt4474SmBFE_40000697.7ALOG_18004698.1NoNoAGRB_76003795.8BurJV3_388394.9SMD_402194.5Smal_383694.7NoNo*eby*ANoNoNoNoNoSMBUR_50075NoNoNoNoNoNoNoNoNoNoUnknown*eby*BNoNoNoNoNoSMBUR_50076NoNoNoNoNoNoNoNoNoNo*eby*CNoNoNoNoNoSMBUR_50074NoNoNoNoNoNoNoNoNoNoNoSmBFE_170290NoNoNoNoAGRB_119011999.7NoNoNoNoNoNoNoNoUnknownNoSmBFE_170289NoNoNoNoAGRB_119011899NoNoNoNoNoNoNoNoNoSmBFE_170292NoNoNoNoAGRB_119012298.1NoNoNoNoNoNoNoNoMFPNoNoNoNoNoNoNoNoNoBurJV3_205092.2NoNoSmal_2022NoNoUnknownRNDNoNoNoNoNoNoNoNoNoBurJV3_205198.5NoNoSmal_2023NoNoOMPNoNoNoNoNoNoNoNoNoBurJV3_205296.7NoNoSmal_2024NoNoRNDNoNoNoNoNoNoNoNoNoBurJV3_2172NoNoNoNoNoNoUnknownMFPNoNoNoNoNoNoNoNoNoBurJV3_2173NoNoNoNoNoNoMFP *acr*ANoNoNoNoNoNoNoAGRB_72005783.4NoNoNoNoSmal_920NoNoTetracycline, ampicillin, puromycin, nalidixic acid, rifampin, chloramphenicolRND *acr*BNoNoNoNoNoNoNoAGRB_72005897.4NoNoNoNoSmal_921NoNo*mdt*ANoNoNoNoNoNoNoNoNoNoNoNoNoSmal_3610SmPIER_53001989.2Novobiocin, deoxycholate*mdt*BNoNoNoNoNoNoNoNoNoNoNoNoNoSmal_3611SmPIER_53002095.4*mdt*CNoNoNoNoNoNoNoNoNoNoNoNoNoSmal_3612SmPIER_53002194.9RNDNoNoNoNoNoNoNoNoNoNoNoNoNoNoNoSmPIER_340003UnknownMFPNoNoNoNoNoNoNoNoNoNoNoNoNoNoNoSmPIER_340004

The SMR Family
--------------

Efflux pumps belonging to the SMR family can export lipophilic compounds used as antimicrobials, primarily quaternary ammonium compounds (QACs), as well as cationic dyes. They have also been shown to confer resistance to multiple beta-lactams, macrolides, and tetracycline. These MDR efflux pumps are usually composed of an inner membrane protein encoded by a single gene. Nevertheless, some SMR efflux pumps require the coexpression of two separate SMR genes to constitute a paired SMR efflux system ([@evv161-B13]). Three genes encoding SMR efflux pumps are present in the nine strains ([table 5](#evv161-T5){ref-type="table"}). Among them, two are homologous to *sug*E from *E. coli* with translated amino acid sequence identity of 53% and 56%, respectively, over 99% of the protein sequence. The SugE efflux pump confers resistance to antiseptic compounds ([table 5](#evv161-T5){ref-type="table"}), but no antibiotics are known to constitute its substrate. The third gene encoding an SMR family efflux pump was found to be homologous to *emr*E from *E. coli* with translated amino acid sequence identity of 60% over the entire protein sequence. The EmrE efflux pump has been shown to confer resistance to beta-lactams, macrolides such as ampicillin and macrolides such as erythromycin and tetracycline, as well as to a variety of QACs such as methyl viologen, tetraphenylphosphonium, benzalkonium, cetyltrimethylammonium bromide (CTAB), cetylpyridinium chloride, and dyes, such as ethidium bromide, acriflavin/proflavin, crystal violet, pyronine and safranine.

The MFS
-------

The MFS constitutes the largest family of transporter proteins. Among the 17 described families belonging to the MFS, 2 of them, the 12-Transmembrane (TM) Drug/H+ Antiporter 1 (DHA-1) family and the 14-TM DHA-2 family are involved in multidrug resistance. Each of these two families encompasses numerous efflux pumps having different substrate specificities and conferring resistance against different antibiotics and other compounds. The 12-TM DHA-1 and 14-TM DHA-2 efflux pumps are usually composed of a single inner-membrane protein encoded by a single gene. However, in Gram-negative bacteria, these MFS encoding genes can be associated with genes encoding members of the MFP family that mediate the drug transport across the outer membrane of the bacteria. In some case, MFP proteins and their respective transport proteins can interact with members of the OMF protein family, which are outer membrane proteins enabling the substrate transport across the outer membrane of the Gram-negative bacteria. Thus, MFS class-like MDR efflux pumps can be encoded from 1, 2, or 3 distinct genes ([@evv161-B28]). Five MFS efflux pumps of the 12-TM DHA-1 and 14-TM DHA-2 families have been identified in all of the *S. maltophilia* genomes ([table 5](#evv161-T5){ref-type="table"}). Among them, three were found in all the strains. One of these three efflux pumps is a tripartite efflux pump belonging to the 14-TM DHA-2 family with its own OMF. This MDR efflux pump is homologous to EmrAB of *E. coli* with translated amino acid sequences of *emr*A and *emr*B sharing about 43% and 49% sequence identity with the *E. coli* homologs, respectively. The EmrAB efflux system is known to confer resistance to some hydrophobic antibiotics, such as nalidixic acid and thiolactomycin, to hydrophobic uncouplers, such as carbonyl cyanide m-chlorophenylhydrazone and tetrachlorosalicylanilide, and to organomercurials. A gene encoding a second inner membrane protein from the 14-TM DHA-2 efflux system family was found in all the strains. This efflux pump is homologous to MdtD, a putative MDR efflux transporter described in *E. coli* with amino acid sequence identity of 49%; however, the substrates of this efflux pump are still to be deciphered. The third universally found MFS putative MDR efflux pump has a single efflux protein that belongs to the 12-TM DHA-1 family. The translated amino acid sequence of the gene encoding this protein has conserved domains with the Bcr/CflA subfamily, which encompasses efflux pumps involved in the resistance to bicyclomycin, sulfathiazole, and chloramphenicol. A second gene encoding an efflux pump of the Bcr/CflA subfamily was found in the environmental strains BurA1 and RR10 belonging to the same phylogenetic group as well as in the environmental strains PierC1 and R551-3 phylogenetically more distant from the main *S. maltophilia* clusters. All of the strains except BurA1 also hold another tripartite MDR efflux system homologous to EmrAB and its associated OMF.

The ABC Transporters Family
---------------------------

ABC transporters are membrane proteins responsible for the uptake and secretion of a wide range of substrates. The ABC transporter family includes polyspecific MDR efflux systems that can accommodate a variety of unrelated substrates. ABC transporters can be composed of a single inner-membrane protein encoded by a single gene or by two half-transporter proteins encoded by two distinct genes. These two proteins assemble into a heterodimeric functional unit. Like the MFS transporter family, ABC transporters can be associated with an MFP protein and sometimes with an OMF protein ([@evv161-B55]). Five putative MDR ABC transporters have been found among the nine genomes. Two of them are present in all of the strains. The first is a tripartite efflux pump composed of an ABC transporter protein associated with an MFP and an OMF. The genes encoding the ABC transporter protein and the MFP are homologous to *mac*A and *mac*B from *E. coli* with translated amino acid sequences identities of 40% and 58%, respectively, over at least 90% of the length of the protein sequence. In *E. coli*, MacAB has been shown to be specifically involved in resistance toward the macrolide class of antibiotics. The second MDR ABC efflux pump is composed of one gene encoding the ATPase domain, one gene encoding the permease domain of the transporter, and one gene encoding a MFP. No homologous genes encoding efflux transporters with known substrates were identified; nevertheless, conserved protein domains and BLAST results suggested the involvement of this efflux pump in MDR mechanisms. The third efflux pump present in all strains is an inner membrane ABC efflux system encoded by the *smr*A gene. This efflux system has been characterized in *S. maltophilia* and is involved in resistance to structurally unrelated compounds including fluoroquinolones, tetracyclines, doxorubicin, and multiple dyes ([@evv161-B2]). Two other bipartite efflux systems composed of one ABC transporter protein and one MFP were found among the genomes. These two efflux systems are also homologous to MacAB from *E. coli*. One of these efflux systems was found in all the strains excepted PierC1 and RR10. The translated amino acid sequence identities of the *S. maltophilia* genes with *mac*A and *mac*B were about 32% and 47%, respectively, over the whole length of the protein sequence. The second was found in the strains JV3 and D457 from the same phylogenetic cluster, as well as in RR10, PierC1, and R551-3. The translated amino acid sequence identities with *mac*A and *mac*B were 37% and 53%, respectively, over the whole length of the protein sequence.

Fusaric Acid Resistance Efflux Pumps
------------------------------------

A tripartite efflux pump composed of a specific fusaric acid resistance inner-membrane protein, an MFP, and an OMF encoded by three distinct genes organized in an operon structure has been described in *S. maltophilia* ([@evv161-B39]). In this survey, two tripartite fusaric acid resistance efflux systems were found. One is present in all the strains; nevertheless, this putative fusaric acid resistance efflux pump has not been characterized yet but the translated amino acid sequences of the three genes encoding this efflux system share conserved domains with fusaric acid resistance proteins. The second tripartite fusaric acid resistance efflux pump has been described in *S. maltophilia* as the FuaABC efflux system encoded by three genes previously reported in the strain K279a genome sequence ([@evv161-B39]). This efflux system has been characterized as conferring resistance against fusaric acid when overexpressed. Except for strain JV3, FuaABC efflux system genes were found in all the strains.

The RND Family
--------------

RND efflux pumps are known to have broad substrate profiles, including antimicrobial drugs from a wide range of classes, organic solvents, and disinfectants. These tripartite efflux systems are composed of an RND inner membrane protein and two additional components, a periplasm-spanning MFP and an OMF that are needed to remove the substrates from the cell. The RND inner-membrane part of the efflux system can also be a heteromultimeric structure of two proteins encoded by two distinct genes organized as part of an operon. The MFP is usually specific to each RND protein and the genes encoding these two proteins generally constitute operons. The OMF can also be encoded in the same operon, but there tend to be fewer different OMFs than RND/MFP pairs in a genome. Nevertheless, some OMFs can associate with numerous MDR efflux pumps belonging to different families to form effective efflux pumps. In *S. maltophilia*, eight operons encoding characterized or putative RND multidrug efflux pumps have been previously described ([@evv161-B22]). Fifteen RND efflux pumps likely to be involved in antibiotic resistance were found among all the genomes, among which seven are present in all the strains ([table 5](#evv161-T5){ref-type="table"}). These seven efflux pumps belong to the eight described RND efflux pumps. Among these efflux pumps, SmeDEF, SmeOP-TolCsm, and SmeVWX are tripartite efflux systems having their own OMF. The TolCsm OMF can probably associate with SmeOP and with other efflux pumps that do not have a specific OMF to constitute effective efflux pumps ([@evv161-B52]). These efflux pumps, encoded by operons of three genes, contribute to the resistance to chloramphenicol, quinolones, macrolides, and tetracycline. The efflux pump SmeIJK encoded by an operon of three genes was also found in all the strains. This efflux pump, composed of two inner-membrane proteins constituting a heteromultimeric structure and a specific MFP, contributes to the resistance to aminoglycosides, fluoroquinolones, and tetracyclines. The three other described RND efflux pumps are encoded by two genes--operons that are encoding the RND protein and the specific MFP. These pumps are SmeGH and SmeMN, which are putatively involved in multidrug resistance mechanisms but for which substrates are unknown, as well as SmeYZ that contributes to aminoglycosides resistance. Surprisingly, the tripartite RND efflux system SmeABC, characteristic of the *S. maltophilia* species, was found in all the strains excepted BurA1 and PierC1. Three bipartite efflux pumps have been identified within particular strains. One has been found only in JV3 and another in R551-3 and RR10. These two efflux pumps contain acriflavin resistance protein-conserved domains. The third one is specific to the strain PierC1 and displays sequence identity of 40% with SmeOP. Three genes encoding an RND efflux pump having the same organization as SmeIJK were found in the strains R551-3 and PierC1. These genes are homologous to the MdtABC efflux pump encoding genes from *E. coli* with 45%, 61%, and 50% translated amino acid identities over at least 90% of the protein sequences. The MdtABC efflux system was shown to confer resistance against novobiocin and deoxycholate. Three tripartite RND efflux pumps have been found only within certain strains. One has been found in the strains BurE1 and RR10, the second in the strains R551-3 and JV3, and the third is specific to the strain BurA1. The genes encoding these tripartite efflux pumps all show conserved amino acid sequences with acriflavin resistance efflux proteins from the RND family but no homologous efflux pumps with known substrates could be attributed.

EbyCAB, a Multiresistant Environmental Strain-Specific RND Efflux Pump
----------------------------------------------------------------------

As mentioned above, an RND efflux pump specific to the MDR environmental strain BurA1 was identified. In addition, this strain does not possess the SmeABC efflux pump ([table 5](#evv161-T5){ref-type="table"}). As this strain has the most significant resistance profile of the study, special attention was paid to the description of this efflux pump, which may have a role in resistance to antibiotics in place of SmeABC. The products of the three genes named *eby*A (SMBUR50075) encoding the MFP unit, *eby*B (SMBUR50076) encoding the RND protein, and *eby*C (SMBUR50074) encoding the OMF constitute the tripartite RND efflux pump EbyCAB. The *eby*CAB genes are organized in an operon-like structure and are preceded by a transcriptional regulator of the TetR family (SMBUR50073) ([fig. 4](#evv161-F4){ref-type="fig"}). The *eby*CAB genes share protein sequence identity of 72.2--99.6% with an RND operon found in the *Cronobacter* and *Xanthomonas* genera from the γ-proteobacteria class, the RND protein (EbyB) having the best similarity between the three genera (99.2% identity, on average). Interestingly, only three *Cronobacter* strains (two *C. universalis* strains and one *C. muytjensii* strain) and two very closely related *Xanthomonas* strains possess this level of similarity. In fact, other strains of these two genera share no significant similarity or possess a level of similarity much lower than what is seen with these five strains ([supplementary fig. S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv161/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv161/-/DC1) online). Given these first observations, it seems that the *eby*CAB operon was acquired recently by horizontal transfer, at least three times independently, for each of these bacterial genera. In addition to these protein sequences exhibiting a very high similarity, protein sequences from five clinical *P. aeruginosa* strains show identity percentages with EbyB sequence of 81.9%, whereas the other RND sequences show identity percentages lower than 70%. A phylogenetic study of the EbyB protein sequence, including most of the best BLAST hits, confirms that the operon *ebyCAB* was probably transferred several times ([supplementary fig. S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv161/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv161/-/DC1) online). F[ig]{.smallcaps}. 4.---Genetic organization of the *eby*CAB genes and adjacent CDS with HGT functions located on a 63-kb genomic island of the chromosome of the strain BurA1. Locus tags are indicated on top of each CDS. CDS colored in green encodes the EbyCAB RND efflux pump specific to the BurA1 strain. CDS colored in yellow and orange are implied in mobile and extrachromosomal element functions, the orange ones belonging to the type IV secretory pathway family. CDS in pink are transcription regulators. INT, integrase; SMC, structural maintenance of chromosome protein.

This *eby*CAB operon is located on a genomic island of 63.3 kb identified by codon usage bias and other characteristics like the presence of an integrase similar to a phage integrase ([fig. 4](#evv161-F4){ref-type="fig"}). Transposon and plasmid transfer genes encoding proteins from the Tra and Trb families and *par*A, *par*B and *rep*A genes, which are implicated in the maintenance and replication of mobile genetic elements, were also found in this genomic island. Most of these genes shared translated amino acid sequence identity of more than 70% over all the protein sequences belonging to the genera *Burkholderia*, *Ralstonia,* and *Acidovorax* from the ß-proteobacteria subclass. Moreover, the average of the CAI (Codon Adaptation Index) values of the whole genomic island (i.e., 57 genes) was significantly lower (*P* \< 0.05; Student test) than those of the 57 upstream or downstream genes. These results suggest that the genomic structure is very mosaic which is typical of most ICE (integrative and replicative element), as defined by [@evv161-B19]. ICE sequences are mobile elements, able to move both within a genome (as a transposon) and between strains through conjugation, after excision and circularization. A phylogenetic study of the integrase sequences shows that this genomic island belongs to the tn4371 ICE family ([supplementary fig. S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv161/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv161/-/DC1) online). Phylogenetic studies from other genes of the genomic island confirm that it belong to this ICE family (data not shown). The closest evolutionary ICE sequences (82.3% identity between the integrase; [supplementary fig. S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv161/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv161/-/DC1) online) were initially described in two soil ß-proteobacteria species (*Cupriavidus metallidurans* CH4 and *Burkholderia gladioli* BSR3). Surprisingly, the genomic islands in *S. maltophila* BurA1, *C. metallidurans* CH4 and *B. gladioli* BSR3 show strong synteny and similarity between all the ICE sequences, except for the *eby*CAB operon and some immediate flanking genes. In the two ß-proteobacteria strains, the efflux pump encoding genes have been replaced by a cluster of genes encoding metabolic functions related to carbon metabolism (*C. metallidurans* CH4) or to aromatic compound degradation (*B. gladioli* BSR3). Moreover, among the sequenced *Stenotrophomonas* strains, only one other strain (EPM1) possesses a similar ICE sequence (96.2% identity between the two integrase; [supplementary fig. S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv161/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv161/-/DC1) online) as the one we have described in BurA1, with its genomic location between genes encoding GMP synthase and a gene encoding an SMS protein, but without the operon *eby*, which is absent ([supplementary fig. S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv161/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv161/-/DC1) online). Although BurA1 and EPM1 are evolutionary closely related ([fig. 2](#evv161-F2){ref-type="fig"}), the presence of tn4371 only in these two strains requires either two recent and independent HGTs, or an ancient gene transfer followed by a recent loss of this genomic island, in addition to the gain or loss of the *eby* operon ([fig. 2](#evv161-F2){ref-type="fig"}). As the integration of an ICE is generally site specific ([@evv161-B89]), two independent integrations of tn4371 in the same place in the genome cannot be excluded.

Finally, we studied the genomic context of the RND operon close to *eby* in the *Xanthomonas* and *Cronobacter* strains (i.e., having more than 99% identity with EbyB). The immediate flanking genes are highly conserved (high synteny and identity) even if there are some chromosomal inversions and gene losses or gains, compared with the BurA1 strain (data not shown). More distant genes around the RND operon also correspond to an ICE structure (transposon plasmid and transfer genes). For the two *Xanthomonas* strains, the contig containing the RND operon available in GenBank is however too short to find the encoding integrase gene. As expected, a phylogenetic study of the integrase sequence from a *Cronobacter* strain (*C. universalis* NCTC9529) confirmed that it belongs to the tn4371 ICE family ([supplementary fig. S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv161/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv161/-/DC1) online). However, although the two ICE bearing genes encoding a near identical RND pump in *S. maltophila* BurA1 and *C. universalis* NCTC9529 belong actually to the same family, these two genomic islands are clearly evolutionarily distant (only 21.4% identity between the two integrase; [supplementary fig. S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv161/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv161/-/DC1) online ), which was confirmed with phylogenetic studies from the other genes of the ICE (data not shown). Surprisingly, the integrase of *C. universalis* NCTC9529 is evolutionarily close to an integrase from *C. metallodurans* CH4 (95.2% identity between the two integrase; [supplementary fig. S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv161/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv161/-/DC1) online), efflux pump encoding genes being replaced by genes encoding aromatic hydrocarbon degradation. The β-proteobacteria *C. metallodurans* CH4 has therefore two *tn4371* ICEs, each one very close to an ICE carrying the genes encoding a same efflux pump in at least two different strains of γ-proteobacteria (i.e., *Stenotrophomonas* and *Cronobacter*).

Discussion
==========

*Stenotrophomonas maltophilia* is a ubiquitous bacterium well known for its multiple antibiotic resistance phenotypes. As an emerging opportunistic pathogen, the antibiotic resistance mechanisms and the genes encoding them are well documented in a clinical context, but little is known on the genetic determinism of the antibiotic resistance in an environmental context. Thus, the aim of this study was to decipher the genetic determinants responsible for the variation of antibiotic resistance phenotypes among *S. maltophilia* strains recovered from the environment. This was made with emphasis on antibiotic resistance efflux pumps, as they are known to be widely involved in MDR ([@evv161-B47]). To this purpose, the entire pool of genetic determinants related to antibiotic resistance was assessed on whole-genome sequences of strains from different sampling origins and antibiotic resistance profiles after having defined their phylogenetic relationships by core genome phylogeny. At the beginning of our study, two genome sequences were available, one from the clinical MDR strain K279a ([@evv161-B22]) and the other from the environmental reference endophytic strain R551-3 ([@evv161-B85]). Based on their exceptionally resistant or sensitive antibiotic resistance profiles, three environmental strains from the team collection were sequenced in this study. During our analysis, other genome sequences from clinical and environmental strains became available ([@evv161-B4]; [@evv161-B53]; [@evv161-B83]; [@evv161-B98]; [@evv161-B80]; [@evv161-B97]) but unfortunately their antibiotic resistance profiles were poorly documented.

In order to have the same level of data on the antibiotic resistance of the three sequenced environmental strains and the two reference strains, automated in vitro antibiotic resistance profiles were determined. Antibiotic susceptibility testing revealed that BurA1 and BurE1 showed resistances against 15 and 12 over 18 antibiotics assayed, respectively, including 8 and 7 antibiotic classes, respectively. If no standardized definition for MDR has been given within the scientific community, the definition most frequently used is "resistant to three or more antimicrobial classes" ([@evv161-B56]). Thus BurA1 and BurE1, which have in common with the MDR reference strain K279a the resistance to seven and six antibiotic classes, can be considered as environmental strains with MDR phenotypes equivalent to that of MDR reference clinical strains. Clinical strains are frequently resistant toward more than three antibiotic classes including carbapenems, aminoglycosides, fluoroquinolones, cephalosporins, polymixins, tetracycline, and penicillins ([@evv161-B54]). Environmental strains with MDR phenotypes have been scarcely reported ([@evv161-B15]; [@evv161-B8]). In soil and rhizosphere, [@evv161-B15] described environmental isolates resistant toward an average of 8 antibiotics of 19 assayed, with 2 isolates resistant to 16 antibiotics and 2 isolates resistant to 14 antibiotics. Unfortunately, detailed antibiotic resistance profiles of each strain were not available, but overall these strains are resistant to the same antibiotic classes than BurA1 and BurE1 (i.e., carboxypenicillins, ureidopenicillins, cephalosporins monobactam, carbapenems, aminoglycosides, quinolones, and polymixins), as well as tetracycline and other classes not assayed in the present study. R551-3 showed resistances toward seven antibiotics belonging to six antibiotics classes. Thus according to the accepted definition of MDR ([@evv161-B56]), it can be considered as an MDR environmental strain that shows an average level of resistance as reported by [@evv161-B15]. As BurA1 and BurE1 were detected in soil fields from various sites that were not exposed to any contaminants (Hien, personal communication), it appears that no antibiotic or anthropic selective pressures are needed to select antibiotic resistance among *S. maltophilia* strains. [@evv161-B8] described four MDR *S. maltophilia* isolates from anthropized aquatic environments, whereas no MDR isolates were isolated from nonanthropized water samples. These isolates were resistant toward a range of 15 and 18 antibiotics from 10 to 13 antibiotics classes including penicillin classes, carbapenems, aminoglycosides, tazobactam, and trimethoprim. This suggests that in some circumstances anthropization could favor antibiotic resistance among *S. maltophilia* isolates. However, it has to be noted that PierC1, an isolate from a heavy metal and antibiotic contaminated soil ([@evv161-B87]), only showed resistance toward imipenem, which is considered to be a natural resistance among all the *S. maltophilia* strains as this antibiotic is added in selective growth media intended for the isolation of *S. maltophilia* ([@evv161-B42]). Thereby PierC1 constitutes an extremely sensitive strain, which complete the range of available antibiotic resistance profiles among environmental strains.

Such variability in antibiotic resistance profiles among strains from various origins raises the question of the genetic link between the resistance profile of those *S. maltophilia* strains and their phylogenetic relationships. Comparative analysis of the 3 genomes sequenced in this study with 11 available genome sequences of *S. maltophilia* revealed a core genome of 1,647 proteins representing approximately 35--45% of the total number of predicted protein-coding genes in any given genome. Consequently, these data suggest that there is tremendous latitude for variation in the genomic content of this species. The phylogenetic analysis did not correlate with the different origins of the strains. Indeed, clusters including environmental and clinical strains were observed. Thus, as previously reported in other ubiquitous Gram-negative species, most of the genes responsible for strain adaptations to its ecological niche and to pathogenesis and virulence are likely to be located on the accessory genome ([@evv161-B59]; [@evv161-B82]; [@evv161-B34]). Despite of a lack of information on the resistance profiles of many strains, the phylogenetic analysis suggested that no distinction between resistant and sensitive strains was possible on the basis of their phylogenetic position. As expected in case of link between resistance phenotype and phylogeny, BurE1 and K279a who share a similar antibiotic resistance profile are phylogenetically closely related. They are grouped in a cluster together with the MDR strain EPM1 and the clinical strain Ab55555. This cluster might only include MDR strains but unfortunately no information on the antibiotic resistance profile of Ab55555 is available yet. Three clusters (SO28 and PML168; BurA1 and RR10; D457, JV3, and AU12-09) possibly include both antibiotic sensitive and resistant strains. Thus, on the basis of our findings it seems that at the whole genome level, antibiotic resistance is not clonal and can be acquired or lost by *S. maltophilia* strains from diverse origins with different genomic background. These observations suggest either that HGT constitutes a key mechanism for the acquisition of drug resistance determinants located on the accessory genome, or that the antibiotic resistance determinants are conserved among all *S. maltophilia* strains regardless of their antibiotic resistance profiles. A study comparing two genomes of *S. maltophilia* revealed that most antibiotic resistant genes are not associated with mobile genetic elements ([@evv161-B78]). Thus, the second assumption might be more likely, modification of resistance phenotype essentially resulting from changes of expression and allelic variations in some conserved genes.

To determine whether the variation in the antibiotic resistance profiles of the strains was due to a different content of genetic determinants encoding resistance mechanisms, the global content of antibiotic resistance genes among nine selected genomes was compared. Between 50 and 56 genes and efflux pump operons associated with antibiotic resistance were identified in each genome. Twenty-two putative β-lactamases, 1 aminoglycoside phosphotransferase as well as 17 efflux pumps that were not, to our knowledge, previously described in *S. maltophilia* were identified during this survey, representing approximately 57% of the total pool of antibiotic resistance determinants found among the genomes. No correlation could be made between the presence or absence of a given antibiotic resistance gene and the resistance profile of an *S. maltophilia* strain. Indeed, substantially all known antibiotic resistance determinants such as *bla*L1 coding a metallo-β-lactamase responsible for the resistance toward imipenem ([@evv161-B93]), *bla*L2 and *amp*C conferring resistance against cephalosporins and penicillins ([@evv161-B94]; [@evv161-B95]), Sm*qnr* conferring low intrinsic resistance against quinolones ([@evv161-B79]; [@evv161-B33]) and *aph*(3′)-IIc encoding an aminoglycoside phosphotransferase enzyme that increases resistance against kanamycin, neomycin, butirosin and paromomycin ([@evv161-B65]), were found among all the strains regardless of their antibiotic resistance profiles or isolation origins. Comparative genomic studies of the MDR origin with other opportunistic pathogens did shed light on major differences in the antibiotic resistance gene content between resistant and sensitive strains ([@evv161-B29]; [@evv161-B43]), but in *S. maltophilia*, most of identified antibiotic resistance genes were present in all the genomes. Only a few antibiotic resistance genes were strain specific, including *cat*, *spg*M ([@evv161-B61]; [@evv161-B51]), and *aac*(6′)-iz ([@evv161-B49]). Nevertheless, the deficiency of these genes did not seem to impact directly the resistance phenotype of the strains as, for example, *aac*(6′)-iz was found to be absent from the genome of BurA1, but this strain is still resistant to all aminoglycosides assayed including tobramycin. Given the high number of determinants putatively involved in aminoglycoside resistance found in each genome, this could be due to functional redundancy. However among the five strains for which the detailed antibiotic resistance profile was determined, BurA1 constitutes the only strain resistant to tobramycin without carrying *aac*(6′)-iz in its genome. Thus, it could be related to a variation in the presence of MDR efflux pumps in *S. maltophilia* among which some are known to utilize aminoglycosides as substrate ([@evv161-B50]; [@evv161-B22]; [@evv161-B32]; [@evv161-B52]).

With such a small variation in the overall content of antibiotic resistance genetic determinants, the differences between the antibiotic resistance profiles could be related to the discrepancy in the content of MDR efflux pumps among the strains, the latter being heavily involved in the MDR among *S. maltophilia* ([@evv161-B96]). As expected, numerous known and putative MDR efflux pumps were identified in each genome. The presence of many efflux pumps encoding genes in *S. maltophilia* has already been described in the first analysis of whole-genome sequence ([@evv161-B22]). As noted in a comparison of two genomes of *S. maltophilia* ([@evv161-B78]), the content of known and putative MDR efflux pumps of the MATE SMR, MFS, and ABC transporter families was greatly conserved between the nine genomes irrespective of their origin and resistance profiles. Two MFS, 2 ABC transporters, 1 fusaric acid resistance protein, and 1 MATE efflux pumps were not identified in all strains ([table 5](#evv161-T5){ref-type="table"}), but no correlation could be made between these differences in efflux pumps content and the origins and/or the resistance profiles observed. This could also be due to functional redundancy as one efflux system homologous to each of these absent efflux pump was identified in each genome. More discrepancies in the content of efflux pumps of the RND family were identified. This family of efflux pumps has been the most extensively studied regarding the impact of the efflux mechanism in *S. maltophilia* MDR strains. Eight MDR efflux pumps of the RND family referred to as Sme efflux pumps specific to *S. maltophilia* species have been described, among which six have been characterized ([@evv161-B5]; [@evv161-B50]; [@evv161-B22]; [@evv161-B20]; [@evv161-B32]; [@evv161-B52]). In their study, [@evv161-B78] identified two additional RND efflux pumps putatively involved in MDR in the genome of the strain R551-3. As it is assumed that all strains of a given species carry the same conserved gene coding for MDR pumps in their chromosome ([@evv161-B6]), all the Sme efflux pumps were expected to be found in every strains of *S. maltophilia*. Seven of these RND efflux pumps (SmeDEF, SmeGH, SmeIJK, SmeMN, SmeOP-TolC, SmeVWX, and SmeYZ) were identified among all the strains. Surprisingly, SmeABC could not be identified in the genomes of the strains BurA1 and PierC1. This is, to our knowledge, the first report of the absence of this *S. maltophilia*-specific efflux pump in strains belonging to this species. In addition to the two uncharacterized RND efflux pumps putatively involved in antibiotic resistance identified in the R551-3 genome ([@evv161-B78]), five additional RND efflux pumps with putative involvement in antibiotic resistance were found among the genomes of the environmental strains only. Thus, on the basis of this analysis, the *S. maltophilia* environmental strains may carry an equal or superior amount of efflux pumps than clinical strains. Maintaining such a large number of efflux pumps in the genomes of environmental strains that are probably not faced with large doses of antibiotics supports the fact that these pumps have other roles than antibiotic resistance and maybe more related to the natural habitat of these bacteria ([@evv161-B68]). Some studies have emphasized the role of these efflux pumps in cell detoxification in strains associated with natural ecosystems ([@evv161-B68]; [@evv161-B71], [@evv161-B72]; [@evv161-B58]) but if detoxification were the only function of these efflux systems, there would be no need to carry a large redundant number of MDR pump paralogs within the chromosome ([@evv161-B58]). Thus it is likely that efflux can assume functions in the plant--bacteria interactions ([@evv161-B60]; [@evv161-B30]), bacterial homeostasis ([@evv161-B45]), virulence ([@evv161-B68]), and cell-to-cell communication ([@evv161-B58]) justifying the conservation of such a significant number of efflux systems.

Nevertheless, the identification of a whole pool of antibiotic resistance genes included in one genome appears insufficient to the determination of the resistance profile of the corresponding strain. Indeed, a link has to be established between the presence of a gene and its functioning, especially in terms of regulation processes and variation of the expression of this gene. Many studies on the role of genetic determinants in the antibiotic resistance phenotypes showed a strong correlation between the overexpression of these determinants and the resulting MDR phenotypes ([@evv161-B1]; [@evv161-B5]; [@evv161-B50]; [@evv161-B51]; [@evv161-B20]). Moreover, mutations inducing allelic variation in an antibiotic resistance gene could also modulate the resistance level conferred by a gene. In *S. maltophilia,* amino acid sequence divergences of the L1 and L2 ß-lactamases have been shown ([@evv161-B18]). Changes in amino acid residues of the L1 ß-lactamase were reported to alter its activity ([@evv161-B11]). Nevertheless, the different allelic variation of the Sm*qnr* gene does not seem to have a significant impact on the quinolone resistance among clinical strains ([@evv161-B31]).

One of the RND efflux pumps named EbyCAB drew particular attention. This efflux system was found on a genomic island in the genome of the environmental MDR strain BurA1 sequenced in this study. The fact that the species-specific pump SmeABC was not found in the genome of BurA1 and that the strain-specific pump EbyCAB was suggests that it was very likely acquired through HGT and that this pump could have an impact on the resistance profile of this MDR strain. Interestingly, the *eby*CAB genes share high protein sequence identity (up to 99.6%) with an RND operon found in the *Cronobacter* and *Xanthomonas* genera from the γ-proteobacteria class. Unfortunately, these homologous RND efflux pumps have not been characterized yet. Although human opportunistic pathogens have been described in two of these bacterial genera (*Stenotrophomonas* and *Cronobacter*), all the strains carrying the efflux pump EbyCAB were isolated from soil or plant. Both the spread of genes encoding this pump and the selection pressures favoring their maintenance in the genome have probably an environmental (not clinical) origin. Thus, further characterization of antibiotic and natural compounds as inducers and substrates of EbyCAB is needed and is currently under investigation with the aim to understand the ecological function of EbyCAB as well as its role in the antibiotic resistance of the strain BurA1. The horizontal transfer of a functional copper resistance efflux system from *S. maltophilia* to a *Xanthomonas* strain was also described by [@evv161-B77]. Moreover, genomic studies conducted on *S. maltophilia* reported the presence of efflux pumps involved in resistance to metals on RGPs probably acquired by HGT ([@evv161-B76]). In *S. maltophilia,* HGT of an efflux pump involved in cadmium resistance from a phylogenetically distant Gram-positive bacterium has also been mentioned ([@evv161-B7]), but no MDR efflux pumps horizontally acquired have been characterized yet. HGT of MDR efflux pumps located on plasmids was reported among Enterobacteriaceae, in particular efflux pumps involved in the resistance to quinolones ([@evv161-B25]) and MDR efflux system ([@evv161-B36]). The transfer of tetracycline resistance efflux pumps presumed to be originating from *Salmonella* was also described in *Shigella* ([@evv161-B37]) and *Acinetobacter baumanii* ([@evv161-B74]). Here, we report, for the first time in *S. maltophilia*, an MDR efflux pump encoded by genes located in a genomic island. This genomic island has the typical structure of an ICE, able to move both in the genome and between strains by conjugation, that is, to spread rapidly in the bacterial community ([@evv161-B19]). These genomic islands allow fast dissemination of genes involved in specific ecological functions, such as the degradation of recalcitrant organic molecules, or the resistance to different solvents or antibiotics ([@evv161-B89]). Surprisingly, even if the same *eby*CAB genes are shared by two ICEs in at least two bacterial genera (i.e., *Stenotrophomonas* and *Cronobacter*), these ICEs are not the same, showing the very high plasticity of these genomic islands capable of exchanging between them their gene content.

To conclude, this study showed that environmental strains and clinical ones shared similar number of resistance determinants. However, some environmental strains carried more efflux pumps than clinical ones. This confirms the findings of [@evv161-B78] concerning the potential broader resistance spectrum of environmental strains of *S. maltophilia*. Although allelic variations and changes of expression are probably responsible for most of the commonly encountered MDR phenotype in *S. maltophilia*, from both clinical and environmental origins, we have shown in this study that some genetic determinants involved in MDR phenotype can also be acquired by HGT. Then, the presence in the environment of MDR resistant strains and the presence of MDR efflux pump on mobile genetic elements raise questions about their potential dissemination at hospital settings and the dissemination of MDR efflux pumps between various clinical pathogens.
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